|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Trade receivables, net | ||||||||||||||||||
| Inventories, net | ||||||||||||||||||
| Prepaid expenses and other current assets (Note 4) | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||
| Other non-current assets (Note 4) | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable (Note 4) | ||||||||||||||||||
| Accrued and other current liabilities | ||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||
| Current portion of long-term debt and other financial liabilities | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||
| Long-term debt | ||||||||||||||||||
| Long-term debt and other financial liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Equity | ||||||||||||||||||
| Common shares, no par value, unlimited shares authorized, 357,057,005 and 354,209,319 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||
| Total Bausch + Lomb Corporation shareholders’ equity | ||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||
| Total equity | ||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||
Loading...
